AccuStem’s StemPrintER Demonstrates Prognostic Utility in TransATAC Cohort Press Release AccuStem’s StemPrintER Demonstrates Prognostic Utility in TransATAC Cohort By accustem|2022-06-08T21:43:08-07:00March 1, 2022|Press Release|
Scheme of Arrangement Effective Press Release Scheme of Arrangement Effective By accustem|2022-06-08T22:06:22-07:00December 1, 2021|Press Release|
Court Sanctions the Scheme of Arrangement Press Release Court Sanctions the Scheme of Arrangement By accustem|2022-06-08T21:56:12-07:00November 26, 2021|Press Release|
Results of Shareholder Meetings Press Release Results of Shareholder Meetings By accustem|2022-06-08T22:25:04-07:00November 25, 2021|Press Release|
Accustem Scheme Document Press Release Accustem Scheme Document By accustem|2022-06-08T22:18:08-07:00November 20, 2021|Press Release|
Accustem Scheme Announcement Press Release Accustem Scheme Announcement By accustem|2022-06-08T22:13:14-07:00November 2, 2021|Press Release|
Distribution Dates for shares and ADRs in Accustem Sciences Limited Press Release Distribution Dates for shares and ADRs in Accustem Sciences Limited By accustem|2022-12-13T08:28:38-08:00September 24, 2020|Press Release|
Accustem Sciences Limited Announces Plans to List in the U.S. Press Release Accustem Sciences Limited Announces Plans to List in the U.S. By accustem|2022-12-13T08:37:56-08:00September 1, 2020|Press Release|
